U.S. Intravascular Lithotripsy Market is projected to reach USD 1.84 billion by 2035, while Europe is set to reach USD 0.84 billion at a 16.51% CAGR, driven by treatment of complex calcified lesions, minimally invasive calcium modification, and expanding peripheral IVL use.

Austin, United States, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Intravascular Lithotripsy Market Size & Growth Analysis:

According to SNS Insider, the global Intravascular Lithotripsy Market was valued at USD 1.01 billion in 2025 and is projected to reach USD 4.19 billion by 2035, expanding at a CAGR of 15.3% from 2026 to 2035. Growth is driven by the growing prevalence of heavily calcified coronary and peripheral artery disease, increased adoption of minimally invasive cardiac procedures, and increasing usage of calcium modification techniques prior to angioplasty and stenting.

Intravascular lithotripsy (IVL) utilizes pressure waves generated via a catheter to fragment vascular calcium deposits without causing harm to soft tissues around it. The increased application of IVL across coronary, peripheral, femoro-popliteal, and below-the-knee procedures along with the developments in forward-firing catheters and disposable catheters has resulted in the widening of the IVL market.


Download the Intravascular Lithotripsy Market Sample Report: https://www.snsinsider.com/sample-request/10827

Calcified Coronary and Peripheral Artery Disease Expands IVL Demand

The increasing instances of coronary and peripheral arteries diseases which have been calcified have created a need for efficient calcium management techniques. IVL is now being widely applied in preparation of calcified lesions prior to balloon angioplasty and stenting, thus creating opportunities for market growth..

Intravascular Lithotripsy Market Key Takeaways

Metric2025 Position / Outlook
Leading productIVL Catheters/Balloons (~56.0% share)
Leading typeCoronary IVL (~58.0% share)
Leading applicationCoronary Artery Disease (~52.0% share)
Leading end userHospitals (~66.0% share)
Largest regional marketNorth America
Fastest-growing regional marketAsia Pacific

Intravascular Lithotripsy Market Regional Outlook

In 2025, North America held a major share of the Intravascular Lithotripsy Market, contributing to about 58.0% of the total market revenue. This region enjoys a high volume of percutaneous coronary interventions along with robust cardiovascular infrastructure and the availability of companies developing IVL technologies.

The U.S. Intravascular Lithotripsy Market was valued at approximately USD 0.53 Billion in 2025 and is projected to reach approximately USD 1.84 Billion by 2035, registering a CAGR of approximately 14.8% during 2026-2035. Increasing adoption of advanced coronary and peripheral IVL systems, growing use in complex calcified lesions, and expanding below-the-knee applications will continue supporting domestic growth.

The Europe Intravascular Lithotripsy Market was valued at USD 0.18 Billion in 2025 and is projected to reach USD 0.84 Billion by 2035, registering a CAGR of 16.51% from 2026 to 2035. Europe held an important presence in the worldwide market due to the growing number of people suffering from cardiovascular diseases, expansion in interventional cardiology facilities, and increased uptake of minimally invasive techniques that modify the calcium.

Asia-Pacific is anticipated to be the fastest-growing region during the forecast period owing to the increasing prevalence of cardiovascular diseases, rising healthcare spending, growth in catheterization laboratories infrastructure, and rising adoption of interventional technologies. China accounted for around 27.6% of total revenue generated in the region in 2025, while India and Japan were considered good sources of growth in the region.

Intravascular Lithotripsy Market Segmentation

By Product

IVL Catheters/Balloons captured a market share of about 56.0% in 2025 due to their crucial nature in delivering lithotripsy in the treatment of coronary and peripheral diseases. The segment of IVL Generators & Consoles will record the highest growth rate as hospitals scale up their IVL setup and new technology companies develop their platforms.

By Type

The Coronary IVL segment led the market with a 58.0% share in 2025. The dominance of this segment can be attributed to the wide range of applications in treating calcified lesions in the coronary arteries, along with clinical experience and growing utilization of IVL during the percutaneous coronary interventions procedure. The Peripheral IVL segment will witness the highest growth due to advancements in catheters used to treat femoro-popliteal, below-the-knee, and other peripheral lesions.

By Application

Coronary Artery Disease accounted for roughly 52.0% of the market share in 2025 attributed to the increasing prevalence of calcified coronary arteries and increasing use of intravascular lithotripsy to prepare the lesion and to dilate the stent. The Below-the-Knee (BTK) Arterial Disease category is projected to register the fastest growth rate due to the advancement in forward-firing IVL technologies for treating peripheral lesions.

By End User

The Hospitals sector accounted for a major market share of around 66.0% in 2025, owing to the presence of advanced cath lab, interventional cardiology, vascular surgery infrastructure, and capability of performing complicated cardiac procedures. The Ambulatory Surgical Centers segment will witness the fastest growth due to the shift of select peripheral interventions to ambulatory care centers.

Explore the Complete Intravascular Lithotripsy Market Report: https://www.snsinsider.com/reports/intravascular-lithotripsy-market-10827

Leading Market Players Listed in this Report are:

  • Johnson & Johnson MedTech (Shockwave Medical)
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Stryker Corporation
  • Koninklijke Philips N.V.
  • Medtronic plc
  • FastWave Medical, Inc.
  • Cagent Vascular, LLC
  • Vantis Vascular, Inc.
  • SIS Medical AG
  • Avinger, Inc.
  • Terumo Corporation
  • Cook Medical LLC
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company (BD)
  • Teleflex Incorporated
  • MicroPort Scientific Corporation
  • Biotronik SE & Co. KG
  • Cardionovum GmbH
  • AngioDynamics, Inc.

Recent Developments:

  • 2025: Shockwave Medical, part of Johnson & Johnson MedTech, launched its Javelin Peripheral IVL Catheter across the United States, providing a forward-IVL platform for highly narrowed and balloon-uncrossable peripheral lesions.
  • 2025: Boston Scientific completed its acquisition of Bolt Medical and introduced its Seismiq intravascular lithotripsy system, expanding its presence in the IVL technology segment.

Exclusive Sections of the Report (The USPs):

  • IVL CATHETER & CALCIUM-MODIFICATION PROCEDURAL METRICS – helps you understand the adoption of intravascular lithotripsy catheters across coronary, peripheral, and complex calcified vascular procedures globally.
  • CORONARY & PERIPHERAL IVL TECHNOLOGY ADOPTION METRICS – helps you evaluate the transition from coronary-focused IVL applications toward peripheral, femoro-popliteal, and below-the-knee arterial interventions globally.
  • IVL GENERATOR & CONSOLE DEPLOYMENT METRICS – helps you analyze investment in lithotripsy generators, console infrastructure, competing platforms, and technology deployment across hospitals and cardiovascular centers globally.
  • CALCIFIED CORONARY & PERIPHERAL ARTERY DISEASE TREATMENT METRICS – helps you identify growth in IVL utilization for complex coronary lesions, peripheral artery disease, and chronic limb-threatening ischemia procedures globally.
  • FORWARD-FIRING & NEXT-GENERATION IVL TECHNOLOGY METRICS – helps you assess adoption of forward-firing, laser-based, electric, and other advanced lithotripsy platforms designed to address balloon-uncrossable and highly calcified lesions.

Buy the Intravascular Lithotripsy Market Report with Competitive Analysis and 2035 Forecast: https://www.snsinsider.com/checkout/10827

Intravascular Lithotripsy Market Report Scope

Report AttributesDetails
Market Size in 2025USD 1.01 Billion
Market Size by 2035USD 4.19 Billion
CAGRCAGR of 15.3% From 2026 to 2035
Base Year2025
Forecast Period2026-2035
Historical Data2022-2024
Key Segments• By Product (IVL Catheters/Balloons, IVL Generators & Consoles, Guidewires & Accessories)
• By Type (Coronary IVL, Peripheral IVL, Others)
• By Application (Coronary Artery Disease, Peripheral Artery Disease, Below-the-Knee (BTK) Arterial Disease, Others)
• By End-User (Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratories)
Regional Analysis/CoverageNorth America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America).

Related Market Reports

Vascular Closure Devices Market Size 2026

Coronary Artery Size, Share 2026

Angioplasty Balloon Market Size 2026

Interventional Cardiology Devices Market Size 2026

Pediatric Interventional Cardiology Market Growth 2026

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

CONTACT: Rohan Jadhav - Principal Consultant
Phone: +1-315-961-9094 (US)
Email: info@snsinsider.com